Showing results (81-90 of 218) with videos related to
Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2021
Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung CancerKathryn C Arbour, Hira Rizvi, Andrew J Plodkowski, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancerJ C Osorio, A Ni, J E Chaft, et al.Journal for Immunotherapy of Cancer|March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapyNaiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2021
Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse EventsJia Luo, Jason A Beattie, Paige Fuentes, et al.NPJ Precision Oncology|July 16, 2024
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapyArielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 23, 2021
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumabMaria Thor, Annemarie F Shepherd, Isabel Preeshagul, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2018
Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of ResistanceHelena A Yu, Ken Suzawa, Emmet Jordan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancerL Derosa, M D Hellmann, M Spaziano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i>-Mutant Lung CancersMichael Offin, Hira Rizvi, Megan Tenet, et al.Cancer Medicine|May 7, 2020
Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumabNarek Shaverdian, Maria Thor, Annemarie F Shepherd, et al.Pageof 22